secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2022-04-06T23:59:59+00:00
Accession:  0001104659-22-043215
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics Chair Frederick Wasserman to not stand for reelection at 2022 Annual Meeting
--------------------------------------------------------------------------------

- Frederick Wasserman, Chair of the Board, will not stand for reelection at the 2022 Annual Meeting.
- He has served on the Board since January 2016 and will continue in his roles until the meeting conclusion.
- His decision is not based on any disagreement with the Company or its management.
- No replacement for the Chair or director position has been announced yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465922043215/0001104659-22-043215-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465922043215/tm2211712d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-043215

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer